Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
32°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by IGC Pharma, Inc.
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
April 16, 2024
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Adds Advisor in Artificial Intelligence
April 09, 2024
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
March 20, 2024
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
March 20, 2024
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
March 12, 2024
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model
February 28, 2024
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a “Buy” Recommendation and $3.00 Price Target
February 23, 2024
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Reports Third Quarter Fiscal 2024 Results
February 16, 2024
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model
February 01, 2024
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s
January 23, 2024
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial
January 17, 2024
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s
December 19, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024
December 13, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials
December 06, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives
November 21, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Reports Second Quarter Fiscal 2024 Results
November 13, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Granted European Patent for Groundbreaking Cannabinoid-Based Pain Topical Relief Therapy
October 19, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Announces Results of its 2023 Annual Stockholders Meeting
August 21, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer’s Candidate Through Phase 2 Clinical Trials
August 14, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the University of Puerto Rico
August 02, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma, Inc. Presenting 6 Posters on the Positive Impact of IGC-AD1 on Neuropsychiatric Symptoms in Dementia at the 2023 Alzheimer’s Association International Conference
July 18, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Reports Financial Results for Fiscal Year Ended March 31, 2023
July 12, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Secures $12 Million Line of Credit from O-Bank Strengthening Efforts in Alzheimer's Research
July 07, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Announces a $3 Million Private Placement of its Common Stock
July 06, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
IGC Pharma Receives Notice of Allowance for Patent on Seizures
June 06, 2023
From
IGC Pharma, Inc.
Via
Business Wire
Tickers
IGC
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.